/ ELV


Elevance Health (ELV) Falls Short of Expectations with Q2 ’25 Results
/ Earnings

Elevance Health (ELV) Falls Short of Expectations with Q2 ’25 Results

Elevance Health reported a 14.3% increase in operating revenue for Q2 2025, although earnings per share fell short of expectations.

July 17, 2025
Elevance Health Reports Better than Expected Results for Q1 2025

Elevance Health Reports Better than Expected Results for Q1 2025

Elevance Health reports a 15% revenue increase in Q1 2025, driven by growth across various segments.

April 22, 2025
Elevance Health (NYSE: ELV) Falls to Deliver on EPS Expectations for Third Quarter

Elevance Health (NYSE: ELV) Falls to Deliver on EPS Expectations for Third Quarter

Elevance Health Inc. (NYSE: ELV) reported its third-quarter performance in 2024 with an operating revenue of $44.7 billion.

October 17, 2024
Elevance Health Beats Expectations with $43.2 B in Q2 Operating Revenue

Elevance Health Beats Expectations with $43.2 B in Q2 Operating Revenue

Elevance Health reported a stable second quarter 2024 performance, with operating revenue slightly decreasing to $43.2 billion.

July 17, 2024
Elevance Health (ELV) Beats EPS Expectations at $10.64 in Q1, Revenue Miss

Elevance Health (ELV) Beats EPS Expectations at $10.64 in Q1, Revenue Miss

Elevance Health, Inc. (NYSE: ELV) showcased strategic advancements with operating revenue reaching $42.3 billion in the Q1.

April 18, 2024

Get Trade Ideas and Market Insights Delivered to You Premarket - Every Day

X